Role of 2-5A-dependent RNase-L in senescence and longevity
- 20 November 2006
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 26 (21) , 3081-3088
- https://doi.org/10.1038/sj.onc.1210111
Abstract
Senescence is a permanent growth arrest that restricts the lifespan of primary cells in culture, and represents an in vitro model for aging. Senescence functions as a tumor suppressor mechanism that can be induced independent of replicative crisis by diverse stress stimuli. RNase-L mediates antiproliferative activities and functions as a tumor suppressor in prostate cancer, therefore, we examined a role for RNase-L in cellular senescence and aging. Ectopic expression of RNase-L induced a senescent morphology, a decrease in DNA synthesis, an increase in senescence-associated β-galactosidase activity, and accelerated replicative senescence. In contrast, senescence was retarded in RNase-L-null fibroblasts compared with wild-type fibroblasts. Activation of endogenous RNase-L by 2-5A transfection induced distinct senescent and apoptotic responses in parental and Simian virus 40-transformed WI38 fibroblasts, respectively, demonstrating cell type specific differences in the antiproliferative response to RNase-L activation. Replicative senescence is a model for in vivo aging; therefore, genetic disruption of senescence effectors may impact lifespan. RNase-L−/− mice survived 31.7% (P+/+ mice providing evidence for a physiological role for RNase-L in aging. These findings identify a novel role for RNase-L in senescence that may contribute to its tumor suppressive function and to the enhanced longevity of RNase-L−/− mice.Keywords
This publication has 37 references indexed in Scilit:
- Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesisNature, 2005
- BRAFE600-associated senescence-like cell cycle arrest of human naeviNature, 2005
- Oncogene-induced senescence as an initial barrier in lymphoma developmentNature, 2005
- Senescence in premalignant tumoursNature, 2005
- HPC1/RNASEL Mediates Apoptosis of Prostate Cancer Cells Treated with 2′,5′-Oligoadenylates, Topoisomerase I Inhibitors, and Tumor Necrosis Factor-Related Apoptosis-Inducing LigandCancer Research, 2004
- Exploration of replicative senescence-associated genes in human dermal fibroblasts by cDNA microarray technologyExperimental Gerontology, 2004
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- A Study of the Interferon Antiviral Mechanism: Apoptosis Activation by the 2–5A SystemThe Journal of Experimental Medicine, 1997
- 2-5A-dependent RNase Molecules Dimerize during Activation by 2-5AJournal of Biological Chemistry, 1995
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958